|
1
|
Fang JB and Wang L: The function of tumor
specific antigen (MAGE) in tumor immunotherapy. Sheng Li Ke Xue Jin
Zhan. 36:273–275. 2005.(In Chinese). PubMed/NCBI
|
|
2
|
Xiao J and Chen HS: Biological functions
of melanoma-associated antigens. World J Gastroenterol.
10:1849–1853. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Xiao J and Chen HS: Biological functions
of melanoma-associated antigens (MAGEs) in cell activities. Ai
Zheng. 24:124–128. 2005.(In Chinese). PubMed/NCBI
|
|
4
|
Sudo T, Kuramoto T, Komiya S, Inoue A and
Itoh K: Expression of MAGE genes in osteosarcoma. J Orthop Res.
15:128–132. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
van der Bruggen P, Traversari C, Chomez P,
Lurquin C, De Plaen E, Van den Eynde BJ, Knuth A and Boon T: A gene
encoding an antigen recognized by cytolytic T lymphocytes on a
human melanoma. J Immunol. 178:2617–2621. 2007.PubMed/NCBI
|
|
6
|
van Baren N, Bonnet MC, Dréno B, Khammari
A, Dorval T, Piperno-Neumann S, Liénard D, Speiser D, Marchand M,
Brichard VG, et al: Tumoral and immunologic response after
vaccination of melanoma patients with an ALVAC virus encoding MAGE
antigens recognized by T cells. J Clin Oncol. 23:9008–9021. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Slingluff CL Jr, Petroni GR, Olson W,
Czarkowski A, Grosh WW, Smolkin M, Chianese-Bullock KA, Neese PY,
Deacon DH, Nail C, et al: Helper T-cell responses and clinical
activity of a melanoma vaccine with multiple peptides from MAGE and
melanocytic differentiation antigens. J Clin Oncol. 26:4973–4980.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mackensen A, Herbst B, Chen JL, Köhler G,
Noppen C, Herr W, Spagnoli GC, Cerundolo V and Lindemann A: Phase I
study in melanoma patients of a vaccine with peptide-pulsed
dendritic cells generated in vitro from CD34(+) hematopoietic
progenitor cells. Int J Cancer. 86:385–392. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chianese-Bullock KA, Pressley J, Garbee C,
Hibbitts S, Murphy C, Yamshchikov G, Petroni GR, Bissonette EA,
Neese PY, Grosh WW, et al: MAGE-A1-, MAGE-A10-, and gp100-derived
peptides are immunogenic when combined with granulocyte-macrophage
colony-stimulating factor and montanide ISA-51 adjuvant and
administered as part of a multipeptide vaccine for melanoma. J
Immunol. 174:3080–3086. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Akiyama Y, Tanosaki R, Inoue N, Shimada M,
Hotate Y, Yamamoto A, Yamazaki N, Kawashima I, Nukaya I, Takesako
K, et al: Clinical response in Japanese metastatic melanoma
patients treated with peptide cocktail-pulsed dendritic cells. J
Transl Med. 3:42005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ge W, Sui YF, Wu DC, Sun YJ, Chen GS, Li
ZS, Si SY, Hu PZ, Huang Y and Zhang XM: MAGE-1/Heat shock protein
70/MAGE-3 fusion protein vaccine in nanoemulsion enhances cellular
and humoral immune responses to MAGE-1 or MAGE-3 in vivo. Cancer
Immunol Immunother. 55:841–849. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ge W, Li Y, Li ZS, Zhang SH, Sun YJ, Hu
PZ, Wang XM, Huang Y, Si SY, Zhang XM and Sui YF: The antitumor
immune responses induced by nanoemulsion-encapsulated
MAGE1-HSP70/SEA complex protein vaccine following peroral
administration route. Cancer Immunol Immunother. 58:201–208. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ge W, Hu PZ, Huang Y, Wang XM, Zhang XM,
Sun YJ, Li ZS, Si SY and Sui YF: The antitumor immune responses
induced by nanoemulsion-encapsulated MAGE1-HSP70/SEA complex
protein vaccine following different administration routes. Oncol
Rep. 22:915–920. 2009.PubMed/NCBI
|
|
14
|
Gkegkes ID and Iavazzo C: Contrast
Enhanced Ultrasound (CEU) using microbubbles for sentinel lymph
node biopsy in breast cancer: A systematic review. Acta Chir Belg.
115:212–218. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Stride E: Physical principles of
microbubbles for ultrasound imaging and therapy. Front Neurol
Neurosci. 36:11–22. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wilson SR and Burns PN:
Microbubble-enhanced US in body imaging: What role? Radiology.
257:24–39. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wan C, Li F and Li H: Gene therapy for
ocular diseases meditated by ultrasound and microbubbles (Review).
Mol Med Rep. 12:4803–4814. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Suzuki R, Oda Y, Utoguchi N, Namai E,
Taira Y, Okada N, Kadowaki N, Kodama T, Tachibana K and Maruyama K:
A novel strategy utilizing ultrasound for antigen delivery in
dendritic cell-based cancer immunotherapy. J Control Release.
133:198–205. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lemmon JC, McFarland RJ, Rybicka JM, Balce
DR, McKeown KR, Krohn RM, Matsunaga TO and Yates RM: In vitro and
in vivo transfection of primary phagocytes via microbubble-mediated
intraphagosomal sonoporation. J Immunol Methods. 371:152–158. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bioley G, Lassus A, Bussat P, Terrettaz J,
Tranquart F and Corthésy B: Gas-filled microbubble-mediated
delivery of antigen and the induction of immune responses.
Biomaterials. 33:5935–5946. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bioley G, Bussat P, Lassus A, Schneider M,
Terrettaz J and Corthésy B: The phagocytosis of gas-filled
microbubbles by human and murine antigen-presenting cells.
Biomaterials. 33:333–342. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ye J, Chen GS, Song HP, Li ZS, Huang YY,
Qu P, Sun YJ, Zhang XM and Sui YF: Heat shock protein 70/MAGE-1
tumor vaccine can enhance the potency of MAGE-1-specific cellular
immune responses in vivo. Cancer Immunol Immunother. 53:825–834.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li S, Zhu C, Fang S, Zhang W, He N, Xu W,
Kong R and Shang X: Ultrasound microbubbles enhance human
β-defensin 3 against biofilms. J Surg Res. 199:458–469. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ma JH, Sui YF, Ye J, Huang YY, Li ZS, Chen
GS, Qu P, Song HP and Zhang XM: Heat shock protein 70/MAGE-3 fusion
protein vaccine can enhance cellular and humoral immune responses
to MAGE-3 in vivo. Cancer Immunol Immunother. 54:907–914. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Suzue K and Young RA: Adjuvant-free hsp70
fusion protein system elicits humoral and cellular immune responses
to HIV-1 p24. J Immunol. 156:873–879. 1996.PubMed/NCBI
|
|
26
|
Mizukami S, Kajiwara C, Ishikawa H,
Katayama I, Yui K and Udono H: Both CD4+ and CD8+ T cell epitopes
fused to heat shock cognate protein 70 (hsc70) can function to
eradicate tumors. Cancer Sci. 99:1008–1015. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Shen ZY, Wu MF, Zhang YX, Shen K and Xia
GL: Treatment of hepatic carcinoma by low-frequency ultrasound and
microbubbles: A case report. Oncol Lett. 9:1249–1253. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wallace N and Wrenn SP: Ultrasound
triggered drug delivery with liposomal nested microbubbles.
Ultrasonics. 63:31–38. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Song S, Guo H, Jiang Z, Jin Y, Wu Y, An X,
Zhang Z, Sun K and Dou H: Self-assembled microbubbles as contrast
agents for ultrasound/magnetic resonance dual-modality imaging.
Acta Biomater. 24:266–278. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lin T, Cai XZ, Shi MM, Ying ZM, Hu B, Zhou
CH, Wang W, Shi ZL and Yan SG: In vitro and in vivo evaluation of
vancomycin-loaded PMMA cement in combination with ultrasound and
microbubbles-mediated ultrasound. Biomed Res Int. 2015:3097392015.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kato S, Shirai Y, Kanzaki H, Sakamoto M,
Mori S and Kodama T: Delivery of molecules to the lymph node via
lymphatic vessels using ultrasound and nano/microbubbles.
Ultrasound Med Biol. 41:1411–1421. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Palekar-Shanbhag P, Chogale MM, Jog SV and
Gaikwad SS: Microbubbles and their applications in pharmaceutical
targeting. Curr Drug Deliv. 10:363–373. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Castle J and Feinstein SB:
Ultrasound-directed, site-specific gene delivery. Methods Mol Biol.
1141:67–76. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Byrn SR and Stowell JG: Drug targeting
using conjugates: The importance of pharmaceutical chemistry. J
Drug Target. 3:239–241. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Jiang J, Xie D, Zhang W, Xiao G and Wen J:
Fusion of Hsp70 to Mage-a1 enhances the potency of vaccine-specific
immune responses. J Transl Med. 11:3002013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yang FY, Fu WM, Chen WS, Yeh WL and Lin
WL: Quantitative evaluation of the use of microbubbles with
transcranial focused ultrasound on blood-brain-barrier disruption.
Ultrason Sonochem. 15:636–643. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hernot S and Klibanov AL: Microbubbles in
ultrasound-triggered drug and gene delivery. Adv Drug Deliv Rev.
60:1153–1166. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Tung YS, Vlachos F, Feshitan JA, Borden MA
and Konofagou EE: The mechanism of interaction between focused
ultrasound and microbubbles in blood-brain barrier opening in mice.
J Acoust Soc Am. 130:3059–3067. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Bai M, Shen M, Teng Y, Sun Y, Li F, Zhang
X, Xu Y, Duan Y and Du L: Enhanced therapeutic effect of Adriamycin
on multidrug resistant breast cancer by the ABCG2-siRNA loaded
polymeric nanoparticles assisted with ultrasound. Oncotarget.
6:43779–43790. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wang X, Gkanatsas Y, Palasubramaniam J,
Hohmann JD, Chen YC, Lim B, Hagemeyer CE and Peter K:
Thrombus-targeted theranostic microbubbles: A new technology
towards concurrent rapid ultrasound diagnosis and bleeding-free
fibrinolytic treatment of thrombosis. Theranostics. 6:726–738.
2016. View Article : Google Scholar : PubMed/NCBI
|
